US 9,809,621 B2Granted

Stable peptide-based PACE4 inhibitors

AssigneeSocpra Sciences Sante Et Humaines S.E.C.

InventorsRobert Day, Witold A. Neugebauer, Yves Dory

Life of this patent

Estimating the term…

Abstract

It is provided PACE4 inhibitors and their uses for treating infection, cancer. Particularly, it is provided a method or use for the treatment of a cancer in a subject, comprising administering to the subject a therapeutically effective amount of the PACE4 inhibitors or the composition disclosed.

Claims11

Dependent claims

A peptide sequence comprising the following formula:

[D-Leu]-LLLRVK-[AMBA].

Dependencies are inferred from the claim text.

Facts

Application: 14/342,041Filed 30 Aug 2012 · us provisional application
Priority: 2 Sep 2011
Published: US 2014/0206622 A124 Jul 2014
Granted: 7 Nov 2017
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

C07K 7/06
Linear peptides containing only normal peptide links: having 5 to 11 amino acids
A61K 38/08
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof: peptides having 5 to 11 amino acids
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K 47/542
The modifying agent being an organic compound: carboxylic acids, e.g. a fatty acid or an amino acid

Family

Application61/530,478Us provisional application · filed 2 Sep 2011
US 2014/0206622 A1Pre-grant publication · published 24 Jul 2014
US 9,809,621 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results